Shares of E.l.f. Beauty Inc. tumbled after hours on Thursday after the cosmetics maker trimmed its full-year outlook, citing “softer-than-expected trends in January.” ...
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback